Shariaportfolio Inc. reduced its stake in shares of Upexi, Inc. (NASDAQ:UPXI – Free Report) by 87.2% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 79,828 shares of the company’s stock after selling 542,900 shares during the quarter. Upexi makes up approximately 0.1% of Shariaportfolio Inc.’s investment portfolio, making the stock its 24th largest position. Shariaportfolio Inc. owned approximately 0.13% of Upexi worth $134,000 as of its most recent filing with the Securities and Exchange Commission.
Other large investors have also recently made changes to their positions in the company. NewGen Asset Management Ltd purchased a new stake in shares of Upexi during the second quarter valued at $1,720,000. J.W. Cole Advisors Inc. purchased a new stake in shares of Upexi during the third quarter valued at $90,000. MMCAP International Inc. SPC purchased a new stake in shares of Upexi during the third quarter valued at $4,425,000. UBS Group AG boosted its stake in shares of Upexi by 1,988.7% during the third quarter. UBS Group AG now owns 757,244 shares of the company’s stock valued at $4,369,000 after purchasing an additional 720,990 shares during the period. Finally, Vanguard Group Inc. boosted its stake in shares of Upexi by 41.9% during the third quarter. Vanguard Group Inc. now owns 710,744 shares of the company’s stock valued at $4,101,000 after purchasing an additional 209,907 shares during the period. 5.68% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
A number of brokerages have recently issued reports on UPXI. Wall Street Zen lowered shares of Upexi from a “hold” rating to a “sell” rating in a research note on Saturday, January 3rd. iA Financial set a $8.00 price objective on Upexi in a report on Tuesday, January 13th. Weiss Ratings restated a “sell (d)” rating on shares of Upexi in a report on Monday, December 29th. Finally, Cantor Fitzgerald restated an “overweight” rating and issued a $2.00 price objective (down from $6.00) on shares of Upexi in a report on Wednesday, February 11th. Two equities research analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average price target of $8.33.
Upexi Stock Performance
UPXI stock opened at $1.01 on Tuesday. The company has a debt-to-equity ratio of 2.96, a current ratio of 2.20 and a quick ratio of 2.19. The business has a 50-day moving average price of $1.04 and a 200 day moving average price of $2.70. The company has a market capitalization of $70.04 million, a P/E ratio of -0.31 and a beta of -0.61. Upexi, Inc. has a 1-year low of $0.54 and a 1-year high of $22.57.
Upexi (NASDAQ:UPXI – Get Free Report) last released its quarterly earnings data on Tuesday, February 10th. The company reported ($2.94) earnings per share for the quarter, missing the consensus estimate of ($0.08) by ($2.86). The firm had revenue of $10.96 million during the quarter, compared to the consensus estimate of $9.42 million. Upexi had a negative net margin of 496.86% and a negative return on equity of 41.47%.
About Upexi
Upexi (NASDAQ: UPXI) is a full-service digital consultancy that partners with brands to design, develop, and deploy digital products and marketing strategies. The company’s expertise spans user experience and interface design, custom software engineering, and data-driven marketing services. By integrating research, creative design, and technical execution, Upexi helps clients accelerate product development cycles and optimize their digital presence.
The firm serves a diverse, global clientele across sectors such as e-commerce, software-as-a-service (SaaS), healthcare, and finance.
Featured Articles
Want to see what other hedge funds are holding UPXI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Upexi, Inc. (NASDAQ:UPXI – Free Report).
Receive News & Ratings for Upexi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Upexi and related companies with MarketBeat.com's FREE daily email newsletter.
